摘要
目的：对参附强心颗粒在心衰治疗中的临床效果进行探究。方法选取我院心内科门诊于2012年11月～2014年9月收治的100例心衰患者，随机分为对照组和观察组各50例患者，对照组患者采用西医标准化治疗，观察组在对照组的基础上增加参附强心颗粒进行治疗。结果对两组患者的临床症状和治疗效果进行对比分析，采用西医标准化治疗的对照组治疗总有效率为84%，加用参附强心颗粒治疗的观察组治疗总有效率为94%。观察组的治疗效果优于对照组，结果对比差异有统计学意义（P〈0.05）。结论参附强心颗粒对于治疗心衰有着良好的治疗效果。
Objective The clinical efficacy of Shenfuqiangxin particles in treatment of cardiac failure is to be investigated. Methods Chose 100 patients with cardiac failure treated in our hospital from November 2012 to September 2014 and separatedthem into control group and study group randomly with 50 patients in each group. 50 patients in control group were given standardized western medicine treatment,while 50 patients in study group were given additional Shenfuqiangxin particles treatment. Results Observe and compare the treatment efficiency of the two groups,the result showed that the treatment efficiency in control group was up to 84%,while the counterpart in study group was up to 94%; the treatment efficiency in study group was much higher than control group,there was a treatment differential between the two groups,and such a differential had statistic value（P〈0.05）. Conclusion Shenfuqiangxin particles are quite efficient in treatment of cardiac failure.
出处
《中国卫生标准管理》
2015年第7期247-248,共2页
China Health Standard Management
关键词
参附强心颗粒
心衰病
治疗
应用
Shenfuqiangxin particles
Cardiac failure
Treatment
Application
